1,331.10
-4.19
(-0.31%)
At close: January 24 at 4:00:02 PM EST
1,331.10
-2.20
(-0.17%)
After hours: January 24 at 4:05:04 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,762,226.00
3,788,309.00
3,919,709.00
3,717,930.00
3,085,177.00
Cost of Revenue
1,524,320.00
1,547,023.00
1,611,667.00
1,546,377.00
1,284,146.00
Gross Profit
2,237,906.00
2,241,286.00
2,308,042.00
2,171,553.00
1,801,031.00
Operating Expense
1,180,855.00
1,161,603.00
1,181,822.00
1,176,817.00
1,016,988.00
Operating Income
1,057,051.00
1,079,683.00
1,126,220.00
994,736.00
784,043.00
Net Non Operating Interest Income Expense
-76,436.00
-77,366.00
-55,392.00
-43,242.00
-38,616.00
Other Income Expense
-25,383.00
-28,589.00
-236.00
-2,133.00
3,316.00
Pretax Income
955,232.00
973,728.00
1,070,592.00
949,361.00
748,743.00
Tax Provision
159,599.00
184,950.00
198,090.00
180,376.00
146,004.00
Net Income Common Stockholders
795,633.00
788,778.00
872,502.00
768,985.00
602,739.00
Diluted NI Available to Com Stockholders
795,633.00
788,778.00
872,502.00
768,985.00
602,739.00
Basic EPS
37.25
36.10
38.79
33.25
25.24
Diluted EPS
37.08
35.90
38.41
32.78
24.91
Basic Average Shares
21,363.86
21,848.12
22,491.79
23,129.86
23,882.65
Diluted Average Shares
21,468.32
21,971.53
22,718.29
23,457.63
24,199.23
Total Expenses
2,705,175.00
2,708,626.00
2,793,489.00
2,723,194.00
2,301,134.00
Net Income from Continuing & Discontinued Operation
795,633.00
788,778.00
872,502.00
768,985.00
602,739.00
Normalized Income
821,186.19
815,293.35
880,290.14
773,228.59
611,204.38
Interest Expense
76,436.00
77,366.00
55,392.00
43,242.00
38,616.00
Net Interest Income
-76,436.00
-77,366.00
-55,392.00
-43,242.00
-38,616.00
EBIT
1,031,668.00
1,051,094.00
1,125,984.00
992,603.00
787,359.00
EBITDA
1,154,649.00
1,172,258.00
1,239,007.00
1,100,660.00
886,068.00
Reconciled Cost of Revenue
1,474,066.00
1,498,072.00
1,564,883.00
1,501,395.00
1,242,102.00
Reconciled Depreciation
122,981.00
121,164.00
113,023.00
108,057.00
98,709.00
Net Income from Continuing Operation Net Minority Interest
795,633.00
788,778.00
872,502.00
768,985.00
602,739.00
Total Unusual Items Excluding Goodwill
-30,679.00
-32,735.00
-9,556.00
-5,239.00
-10,516.00
Total Unusual Items
-30,679.00
-32,735.00
-9,556.00
-5,239.00
-10,516.00
Normalized EBITDA
1,185,328.00
1,204,993.00
1,248,563.00
1,105,899.00
896,584.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-5,125.81
-6,219.65
-1,767.86
-995.41
-2,050.62
12/31/2020 - 11/14/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
WAT Waters Corporation
411.30
-0.36%
IDXX IDEXX Laboratories, Inc.
435.33
+0.69%
IQV IQVIA Holdings Inc.
204.33
-0.81%
MEDP Medpace Holdings, Inc.
344.07
-1.10%
A Agilent Technologies, Inc.
151.44
-0.66%
LH Labcorp Holdings Inc.
246.00
+0.69%
SHC Sotera Health Company
13.65
-0.29%
QGEN Qiagen N.V.
45.63
-0.44%
ICLR ICON Public Limited Company
200.48
-1.09%
CRL Charles River Laboratories International, Inc.
164.97
-1.13%